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Kikuchi-Fujimoto disease (KFD) is a rare form of painful lymphadenopathy, usually cervical, which is more common in Southeast
Asia and rarely reported from Africa. Symptoms are usually nonspeciﬁc (fever, night sweats, etc.), and can mimic more common
diseases such as tuberculosis (TB) in endemic areas. We report a case of a 29-year-old black African woman who was admitted
with headache, neck pain, fever, and lymphadenopathy. She was found to have aseptic meningitis, eventually attributed to TB
based on cervical node biopsy, although further histology suggested KFD. Blood tests for systemic lupus erythematosus (SLE) were
negative; she had already been commenced on anti-TB treatment and had responded well and so was continued with this therapy.
She was also later diagnosed with Hashimoto’s thyroiditis 3 months after her diagnosis of KFD. Five months after stopping TB
treatment, she was readmitted with the same symptoms and associated painless lymphadenopathy. Repeat biopsy was morphologically similar to that of 2017, and repeat evaluation conﬁrmed SLE. She has since been managed by a rheumatologist and
continues to do well.

1. Introduction
Kikuchi-Fujimoto disease (KFD) is a rare form of painful
lymphadenopathy which is more common in Southeast
Asia. KFD is not very well described in Africa, with very few
reports described in the literature. The lymphadenopathy is
usually cervical with associated nonspeciﬁc symptoms of
fever and night sweats, which makes the diagnosis more
challenging as the diﬀerential diagnosis is wide. We describe
a young female, who presented with aseptic meningitis
initially thought to be due to tuberculous meningitis and
later conﬁrmed to have KFD on lymph node biopsy, and
subsequently diagnosed with Hashimoto’s thyroiditis and
systemic lupus erythematosus (SLE) 3 and 18 months after
initial presentation.

2. Case Presentation
A 29-year-old black African woman presented to the
emergency department with headache and fever for 5 days.

Brain imaging was normal, and lumbar puncture for cerebrospinal ﬂuid (CSF) analysis showed a raised white cell
count (WBC) of 31/mm3 with 95% lymphocytosis, elevated
CSF protein, and borderline high CSF adenine deaminase
levels of 18.1 U/L. CSF Ziehl–Neelsen stain, GeneXpert, and
culture for Mycobacterium tuberculosis (TB) were negative.
Blood tests are in accordance with Table 1. Her headache and
fever resolved with oral paracetamol, and she was discharged
with a diagnosis of aseptic meningitis.
However, she was readmitted with worsening neck pain
and headache 2 weeks later and was found to have signiﬁcantly enlarged cervical lymph nodes. Further evaluation
with an MRI scan of the neck showed features in keeping
with TB lymphadenitis. A repeat of laboratory workup (refer
to Table 1) remained negative. She also had a positive EBV
IgG but with a negative serum IgM. A cervical lymph node
was biopsied. Histopathological examination revealed necrotizing lymphadenitis with no granulomas (Figures 1(a)
and 1(b)). Since the histologic appearance was indistinguishable from that of TB lymphadenitis, the patient
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Table 1: Laboratory results summarized from 2017 to 2019.

Variable
White blood cell
Neutrophil count
Lymphocyte count
Hemoglobin
Platelet count
ESR (Erythrocyte
sedimentation rate)
CRP (C-reactive protein)
AST (aspartate transaminase)
ALT (alanine transaminase)
Creatinine
HIV Elisa
CSF:
Cell count
Neut
Lymph
Glucose
Protein
Tb Gene expert
CSF adenine deaminase
CSF culture
CSF viral PCRherpes + enterovirus

Reference range
9/L

4–10 (∗10 )
2–7 (∗109/L)
1–3 (∗109/L)
11.5–16.5 (g/dl)
150–450 (∗109/L)

0–5 (mm3)
%
%
2.22–3.89
(mmol/l)
0.15–0.45 (g/l)

July
2018

Sept 2017

2.51
1.16
1.10
10.2
118

3.19
2.12
0.81
11
153

2.06
1.14
0.80
11
85

44

61

1.63
22
17.7

15.1
23.5
13.9

33.4
15.6

65

59

60

Neg

Neg

31.25
6
94

295
4
96

<5

2.39

3.51

2.69

0.52

0.56
Neg
18.41
No growth

0.44
Neg
0.29
No growth

0–20 (mm/hr)
0–5 (mg/l)
0–35 (U/L)
0–35 (U/L)
58–98
(micromol/l)

Jan
2018

Aug 2017

0–5 (U/L)
No growth

Neg

Neg

Neg

IgG-positive
IgM-neg

EBV (Epstein-Barr virus)
Tropical fever screen(i) Malaria antigen
(ii) Leptospira
(iii) Rickettsia
(iv) Dengue
(v) West Nile virus
(vi) Chikungunya
Malaria parasite
Blood culture
Urine culture

Neg

Absent
No growth
No growth

ANA (antinuclear antibody)

Neg

Absent
No growth
No growth
Positive 1 : 320
speckled
Positive for SS-A/
RO-52
Normal
Neg
Neg
Neg
Normal
Normal

Neg

ENA
Complement 3/4
Anti-dsDNA
Antiphospholipid antibody
Direct Coombs test
Ferritin
Lipid proﬁle
TSH (thyroid stimulating
hormone)
T3
T4
Anti-TPO antibodies
Antithyroglobulin
TSH receptor antibodies
Lymph node biopsy
Tissue Tb culture
Bone marrow aspirate

Feb 2019

Neg

13–150 (ng/ml)
0.27–4.2 (pg/ml)
2–4.4 (pg/ml)
0.97–1.58 (ng/
ml)
<34 (IU/ml)
<115 (IU/ml)
<1.22

1.68

49.77

25.24

4.23

2.88

1.67

2.97

1.87

0.87

0.32

0.84

0.86

290
226
0.468
Refer to Figures 1(a) and
1(b)
Neg

Refer to Figure 1(c)
Normocellular
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(a)

(b)

(c)

Figure 1: (a) Lymph node biopsy 2017 (low-power view): partial eﬀacement of architecture with large area of necrosis with no acute
inﬂammatory cell inﬁltrate in keeping with Kikuchi’s disease. (b) Lymph node biopsy 2017 (high-power view): numerous apoptotic bodies
with histiocytes. (c) Lymph node biopsy 2019: numerous foci of necrosis with apoptotic bodies with scattered histiocytes. Absence of acute
inﬂammatory inﬁltrate and hematoxylin bodies in keeping with Kikuchi’s disease.

was commenced on TB treatment (ATT) and was reviewed
in a clinic 3 weeks later and found to have improved
signiﬁcantly.
The slides were sent for a second opinion overseas
(USA), where the cervical biopsy was noted to show marked
architectural eﬀacement with large areas of necrosis containing abundant apoptotic debris. The adjacent viable areas
contained numerous histiocytes, small lymphocytes, occasional plasma cells, and immunoblasts (Figures 1(a) and
1(b)). Hematoxylin bodies were not identiﬁed. Immunohistochemistry performed on the slides was CD20/PAX5 (Bcell marker)-positive, CD68 (histiocyte marker)-positive,
and CD123 (plasmacytoid dendritic cells)-positive with a Ki
of 67–60%.
These ﬁndings were in keeping with a diagnosis of
histiocytic necrotizing lymphadenitis likely secondary to
either KFD or SLE. However, given the patient was
responding well to the TB therapy and she had screened
negatively for SLE, she was continued on the treatment.
Three months into her TB treatment, she was found to have
an elevated thyroid stimulating hormone (TSH) of 47 pg/ml

with low thyroxine and thyronine levels and positive antithyroid peroxidase and thyroglobulin antibodies in keeping
with Hashimoto’s thyroiditis. The patient completed 12
months of TB treatment and remained well and was
discharged.
However, 5 months later, she presented to the infectious
disease’s clinic with a 1-month relapse of the same symptoms. She reported a history of travel to a malaria-endemic
region 2 weeks prior and had taken a complete course of selfprescribed antimalarial medication with no resolution of
symptoms. On examination, she had a temperature of 38°C
but otherwise normal vital signs and large >1 cm bilateral
nontender nonmatted upper cervical lymphadenopathy, but
otherwise a normal physical examination with no
meningism.
Investigations on this occasion are summarized in
Table 1.
Interestingly, the repeat autoimmune screen revealed
ANA positive with titers of 1 : 320 and a speckled pattern.
Her ENA anti-SS-A/RO-52 was also positive. The remainder
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of her evaluation was unremarkable except for persistent
leucopenia, anemia, and thrombocytopenia.
She was reviewed by the rheumatologist and diagnosed
as a case of systemic lupus erythematosus after she met 4
components of the SLICC criteria which included thrombocytopenia, leucopenia, arthritis, and positive ANA. Her
Anti-Ro antibody was also positive and even though not part
of the SLICC criteria is still in keeping with the diagnosis of
SLE. While in hospital, her fevers settled spontaneously with
antipyretics. At the time of discharge, she was initiated on
prednisolone, azathioprine, and hydroxychloroquine which
she is currently on and is asymptomatic. She currently remains on follow-up in the Rheumatology clinic.

3. Discussion
Kikuchi-Fujimoto disease, also known as histiocytic necrotizing lymphadenitis, was ﬁrst described in 1972 [1]. It is a
rare self-limiting lymphadenopathy, more commonly described in females, those aged 20–40 years and are of
Southeast Asia origin [2, 3]. Although less common within
the African population, a few cases of the disease have been
reported from Gabon, Senegal, Morocco, and Tunisia [4–6].
The disease aﬀects both adults and children. The sex ratio is
variable in the pediatric age group with males aﬀected more
than females, which is reversed in adults [7].
The exact pathophysiology of KFD is not known, but the
two theories postulated are infectious and autoimmune
etiology [8]. Xu et al. identiﬁed CMV,EBV, HHV-6, HHV-7,
Parvovirus B19, and mycobacterial species from lymph node
samples of 153 patients in China with KFD [9]. KFD has
been described in association with SLE, Still’s disease,
Wegener’s granulomatosis, Graves’ disease, and Sjogren’s
disease [3]. Tanaka et al. found higher frequencies of the
HLA DPA1 ∗ 01 and DPB1 ∗ 0202 allele in Japanese patients
with KFD [10]. Familial cases of KFD have been reported in
the literature [11].
The largest published series of 244 KFD cases has shown
that fever (35%), fatigue (7%), and joint pain (7%) are the
most frequent symptoms, and lymphadenopathy (100%),
leucopenia (43%), high erythrocyte sedimentation rate
(40%), anemia (23%), and erythematous rashes (10%) are the
most common ﬁndings [12]. Our patient had high fever,
lymphadenopathy, leukopenia, anemia, and high ESR.
Cervical lymphadenopathy is the commonest site for
lymphadenopathy and is usually painful [13].
The clinical picture of KFD is often nonspeciﬁc and can
be in keeping with several diagnoses such as infectious
mononucleosis, bacterial lymphadenitis (mainly tuberculosis which is highly endemic in Africa), malignant lymphoma, or metastatic cancer [12]. The nonspeciﬁc nature of
presentation is associated with diagnostic delay and misdiagnosis of patients [14, 15], especially in TB endemic
regions such as Kenya, where patients get unnecessary ATT
treatment.
Baenas et al. noted three patterns of presentation of
association between KFD and SLE which are before the onset
of SLE (30%), simultaneous occurrence of both disorders
(47%), and KFD after SLE (23%) [16]. Goldblatt et al.
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reported 4 cases of patients who developed SLE after 4–13
months of diagnosis with KFD [17]. Since SLE evolves over
many years and patients may not meet the diagnostic criteria
at onset or in the initial phases of the disease, it is likely that
the initial diagnosis of KFD in this patient may have been an
attenuated form of SLE [18]. However, it remains diﬃcult to
reach this conclusion since the diagnosis is dependent on
standard diagnostic criteria which our patient did not meet
until much later in the disease. Interestingly, she has not had
any ﬂares of her disease following the initiation of her
treatment for SLE, and it remains unclear whether her initial
response to the anti-TB medication was more due to the
steroids used in the treatment of CNS tuberculosis. Due to
the association of KFD with SLE, follow-up and screening of
patients with KFD for later diagnosis of SLE are recommended [19].
CNS manifestations of KFD are rare, and so far, aseptic
meningitis, encephalitis, and cerebellar ataxia have been
reported in the literature [20, 21]. Aseptic meningitis is the
commonest neurological presentation of Kikuchi’s disease
[22]. The CSF white cell count may range from 60 to
170 mm3 and may present as recurrent meningitis within
intervals of 1 month–11 years [23]. The diagnosis of KFD as
a cause of the aseptic meningitis is made following exclusion
of other potential reversible causes.
Hashimoto’s thyroiditis has also been associated with
Kikuchi disease. In majority of the cases, KFD and Hashimoto’s thyroiditis occurred concurrently; however, in three
cases, the diagnosis of Hashimoto’s thyroiditis preceded that
of KFD [24]. Previous reported cases note that it is more
common in females and may be positive for ANA, complement, and antiphospholipid antibodies. Most reported
cases complete resolution within a year following supportive
care in some patients and steroids in others [24]. We came
across a case report of a 17-year-old female with concurrent
SLE and Hashimoto’s thyroiditis who responded well to
steroids and hydroxychloroquine. [25] Similarly, Aqel et al.
reported a case of KFD in Saudi Arabia with Hashimoto’s
thyroiditis and mixed connective tissue disease [26].
The diagnosis of Kikuchi-Fujimoto disease is made on
biopsy. Histologically, lymph nodes usually have partially
preserved architecture with follicular hyperplasia. Necrotic
foci show abundant karyorrhectic nuclear debris and a large
accumulation of histiocytes at the edge of necrosis. The
histiocytes in KFD are positive for lysozyme, myeloperoxidase, CD68, CD163, and CD4. The lymphocytes in the
lesions are mostly CD3-positive T cells demonstrating a
predominance of CD8 compared with CD4, with very few
CD20-positive B cells [3]. In contrast, lymphadenitis from
TB classically has the presence of well/poorly deﬁned
granulomas with areas of caseous necrosis [27]. The proliferative stage of KFD may be confused with lymphoma due
to presence of large atypical cells and immunoblasts of T-cell
lineage origin [18].
There is no consensus regarding treatment for this
disease. Patients with mild disease respond to supportive
care with antipyretics and NSAIDs. In contrast, those with
extranodal disease with CNS and lung involvement may
respond to short courses of corticosteroids [28].
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During the ﬁrst admission, the patient was on dexamethasone as part of her TB meningitis treatment. This
could explain the initial resolution of her symptoms. Irrespective of the form of intervention, the prognosis of the
condition is reported as favorable. However, there have been
reported cases of death especially in patients who develop
DIC [29].
Song et al. reported a higher incidence rate of relapse in
ANA-positive cases and identiﬁed fever, fatigue, extranodal
involvement, and positive ﬂuorescence antinuclear antibody
as predictive factors for relapse [30].
To the best of our knowledge, very few cases of this
disorder have been reported so far from Africa. The challenges with making this diagnosis we believe are multiple
including lack of clinician familiarity with disorder, few case
reports, nonspeciﬁc signs and symptoms, poor laboratory
support, and presence of alternative diagnosis especially
tuberculosis in our set up.

Consent
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Written informed consent for publication of the clinical
details and clinical images was obtained from the patient.
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Médecine Tropicale, vol. 70, no. 2, pp. 175-176, 2010.
[6] F. El Mezni, K. Mrad, A. el Mezni-Benzarti, R. Zermani,
A. Ben Abdeladhim, and S. Ben Jilani, “Kikuchi-Fujimoto
subacute necrotizing lymphadenitis: two histologic forms

[17]

[18]
[19]

[20]

[21]

[22]

observed in the same patient,” Annales de Pathologie, vol. 18,
no. 5, pp. 422–424, 1998.
T. Y. Kim, K.-S. Ha, Y. Kim, J. Lee, K. Lee, and J. Lee,
“Characteristics of Kikuchi-Fujimoto disease in children
compared with adults,” European Journal of Pediatrics,
vol. 173, no. 1, pp. 111–116, 2014.
J. M. Singh and C. B. Shermetaro, “Kikuchi-Fujimoto disease
in Michigan: a rare case report and review of the literature,”
Clinical Medicine Insights: Ear, Nose and Throat, vol. 12, 2019.
Z. Xu, Y. Liu, H. Li et al., “Detection of mycobacterial and viral
DNA in Kikuchi-Fujimoto disease: an analysis of 153 Chinese
pediatric cases,” Science China Life Sciences, vol. 60, no. 7,
pp. 775–777, 2017.
T. Tanaka, M. Ohmori, S. Yasunaga, K. Ohshima, M. Kikuchi,
and T. Sasazuki, “DNA typing of HLA class II genes (HLADR, -DQ and -DP) in Japanese patients with histiocytic
necrotizing lymphadenitis (Kikuchi’s disease),” Tissue Antigens, vol. 54, no. 3, pp. 246–253, 1999.
A. R. A. Amir, S. S. Amr, and S. S. Sheikh, “Kikuchi-Fujimoto’s disease: report of familial occurrence in two human
leucocyte antigen-identical non-twin sisters,” Journal of Internal Medicine, vol. 252, no. 1, pp. 79–83, 2002.
Y. Kucukardali, E. Solmazgul, E. Kunter, O. Oncul,
S. Yildirim, and M. Kaplan, “Kikuchi-Fujimoto disease:
analysis of 244 cases,” Clinical Rheumatology, vol. 26, no. 1,
pp. 50–54, 2007.
G. Dumas, V. Prendki, J. Haroche et al., “Kikuchi-Fujimoto
disease: retrospective study of 91 cases and review of the
literature,” Medicine, vol. 93, no. 24, pp. 372–382, 2014.
C. McKenna, T. Whitﬁeld, N. Patel, and A. Bonington, “TB or
not to be? Kikuchi-Fujimoto disease: a rare but important
diﬀerential for TB,” BMJ Case Reports, vol. 2017, Article ID
bcr2016217500, 2017.
M. Mahfoudhi, I. Gorsane, S. Turki, and T. B. Abdallah,
“Kikuchi-Fujimoto disease mimicking tuberculosis,” International Journal of Clinical Medicine, vol. 6, no. 10,
pp. 725–728, 2015.
D. Baenas, F. Diehl, M. Haye Salinas, V. Riva, A. Diller, and
P. Lemos, “Kikuchi-Fujimoto disease and systemic lupus
erythematosus,” International Medical Case Reports Journal,
vol. 9, pp. 163–167, 2016.
F. Goldblatt, J. Andrews, A. Russell, and D. Isenberg, “Association of Kikuchi-Fujimoto’s disease with SLE,” Rheumatology, vol. 47, no. 4, pp. 553-554, 2007.
D. Deaver, P. Horna, H. Cualing, and L. Sokol, “Pathogenesis,
diagnosis, and management of Kikuchi-Fujimoto disease,”
Cancer Control, vol. 21, no. 4, pp. 313–321, 2014.
R. F. Dorfman and G. J. Berry, “Kikuchi’s histiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis
on diﬀerential diagnosis,” Seminars in Diagnostic Pathology,
vol. 5, no. 5, pp. 329–345, 1988.
H. Kido, O. Kano, A. Hamai et al., “Kikuchi-Fujimoto disease
(histiocytic necrotizing lymphadenitis) with atypical encephalitis and painful testitis: a case report,” BMC Neurology,
vol. 17, no. 1, p. 22, 2017.
D. B. Jasti, S. V. N. Prasad, T. Naveen, and B. Vengamma,
“Kikuchi-Fujimoto disease presenting as brainstem encephalitis with secondary blepharospasm,” Journal of Neurosciences in Rural Practice, vol. 7, no. 1, pp. 157–160, 2016.
B. F. Khishfe, L. M. Krass, and E. K. Nordquist, “Kikuchi
disease presenting with aseptic meningitis,” The American
Journal of Emergency Medicine, vol. 32, no. 10, pp. 1298.e1–
1298.e2, 2014.

6
[23] T. Komagamine, T. Nagashima, M. Kojima et al., “Recurrent
aseptic meningitis in association with Kikuchi-Fujimoto
disease: case report and literature review,” BMC Neurology,
vol. 12, p. 112, 2012.
[24] E. J. Lee, H. S. Lee, J. E. Park, and J. S. Hwang, “Association
Kikuchi disease with Hashimoto thyroiditis: a case report and
literature review,” Annals of Pediatric Endocrinology &
Metabolism, vol. 23, no. 2, pp. 99–102, 2018.
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no. 10, pp. 836–838, 1996.
[26] N. M. Aqel, S. S. Amr, M. M. Najjar, and K. Henry, “Kikuchi’s
lymphadenitis developing in a patient with mixed connective
tissue disease and Hashimoto’s thyroiditis,” Rheumatology,
vol. 36, no. 11, pp. 1236b–1238b, 1997.
[27] H. G. E. Ahmed, A. S. Nassar, and I. Ginawi, “Screening for
tuberculosis and its histological pattern in patients with enlarged lymph node,” Pathology Research International,
vol. 2011, Article ID 417635, 4 pages, 2011.
[28] A. Youssef, R. Ali, K. Ali, and Z. AlShehabi, “Kikuchi–
Fujimoto disease: a case report of a multi-drug resistant,
grueling disease,” Oxford Med Case Reports, vol. 2017, no. 6,
2017.
[29] B. Barbat, R. Jhaj, and D. Khurram, “Fatality in KikuchiFujimoto disease: a rare phenomenon,” World Journal of
Clinical Cases, vol. 5, no. 2, p. 35, 2017.
[30] J. Y. Song, J. Lee, D. W. Park et al., “Clinical outcome and
predictive factors of recurrence among patients with Kikuchi’s
disease,” International Journal of Infectious Diseases, vol. 13,
no. 3, pp. 322–326, 2009.

Case Reports in Medicine

MEDIATORS
of

INFLAMMATION

The Scientific
World Journal
Hindawi Publishing Corporation
http://www.hindawi.com
www.hindawi.com

Volume 2018
2013

Gastroenterology
Research and Practice
Hindawi
www.hindawi.com

Volume 2018

Journal of

Hindawi
www.hindawi.com

Diabetes Research
Volume 2018

Hindawi
www.hindawi.com

Volume 2018

Hindawi
www.hindawi.com

Volume 2018

International Journal of

Journal of

Endocrinology

Immunology Research
Hindawi
www.hindawi.com

Disease Markers

Hindawi
www.hindawi.com

Volume 2018

Volume 2018

Submit your manuscripts at
www.hindawi.com
BioMed
Research International

PPAR Research
Hindawi
www.hindawi.com

Hindawi
www.hindawi.com

Volume 2018

Volume 2018

Journal of

Obesity

Journal of

Ophthalmology
Hindawi
www.hindawi.com

Volume 2018

Evidence-Based
Complementary and
Alternative Medicine

Stem Cells
International
Hindawi
www.hindawi.com

Volume 2018

Hindawi
www.hindawi.com

Volume 2018

Journal of

Oncology
Hindawi
www.hindawi.com

Volume 2018

Hindawi
www.hindawi.com

Volume 2013

Parkinson’s
Disease

Computational and
Mathematical Methods
in Medicine
Hindawi
www.hindawi.com

Volume 2018

AIDS

Behavioural
Neurology
Hindawi
www.hindawi.com

Research and Treatment
Volume 2018

Hindawi
www.hindawi.com

Volume 2018

Hindawi
www.hindawi.com

Volume 2018

Oxidative Medicine and
Cellular Longevity
Hindawi
www.hindawi.com

Volume 2018

